Subjects Content

Welcome to IgMin Research - A BioMed & Engineering Open Access Journal, your gateway to a diverse world of scientific exploration and innovation. We proudly stand at the forefront of scholarly dissemination, bringing together the realms of Biology, Medicine and Engineering under a single umbrella. With a commitment to open access and knowledge democratization, we aim to empower researchers, scholars, and enthusiasts across the globe to explore, contribute, and collaborate.

Biology

Explore the intricate world of living organisms through disciplines such as Zoology, Histology, and Microbiology. Immerse yourself in the complexities of genomics and molecular biology, uncover the mysteries of taxonomic systems, and delve into the world of human biology. Venture into the realms of chemistry, from Organic Chemistry to Physical Chemistry, and explore the delicate balances of Earth's ecosystems through Atmospheric Science and Ecology....

Medicine

Discover the intricacies of the human body and its ailments through the prism of Medical Sciences. Journey through disciplines like Physiology, Pharmacology, and Anatomy, and explore the frontiers of Molecular Medicine and Immunology. Engage in the discourse on Clinical Trials and Health Economics, and unravel the complexities of Pain Management and Infectious Diseases.

Engineering

Immerse yourself in the realm of engineering marvels, from Control Engineering and Power Engineering to Materials Engineering and Mechanical Engineering. Uncover the mysteries of Signal Processing and delve into the precision of Instrumentation. Navigate the world of Automation and Artificial Intelligence, and witness the convergence of disciplines in Mechatronics Engineering and Biomedical Engineering.

General Science

Explore the complexities of the natural world through the lens of General Science. Delve into fields like Physics, Chemistry, Biology, and Earth Sciences, and examine cutting-edge topics in Environmental Science and Engineering. Engage in discussions on scientific innovations and the impact of research on society and health.

Members Content

We foster partnerships that bring together diverse perspectives to drive faster solutions.

Articles Content

We foster partnerships that bring together diverse perspectives to drive faster solutions.

Explore Content

We foster partnerships that bring together diverse perspectives to drive faster solutions.

Identify Us

We foster partnerships that bring together diverse perspectives to drive faster solutions.

Search

Explore Section

Content for the explore section slider goes here.

Abstract

Abstract at IgMin Research

We foster partnerships that bring together diverse perspectives to drive faster solutions.

Medicine Group Mini Review Article ID: igmin241

A Case of Facial Erysipelas with Necrosis of the Upper Eyelid

Dentistry Affiliation

Affiliation

Abstract

Erysipelas is a superficial cutaneous process that is usually restricted to the dermis, but with prominent lymphatic involvement commonly caused by streptococci. Here, we report an unusual case of primary gangrenous-phlegmonous erysipelas of the face with necrosis of the upper eyelid. Diagnosing facial erysipelas in this case was particularly challenging due to the atypical clinical and laboratory features, possibly caused by secondary immunodeficiency. A unique aspect of this case is that the disease started without the typical early symptoms, such as a prodrome. The patient did not initially show signs of general intoxication but instead presented with a local skin lesion before developing a fever. The characteristic redness and distinct borders commonly associated with erysipelas were also absent. This case demonstrates primary erysipelas of the face in a gangrenous-phlegmonous form, resulting in the development of upper eyelid necrosis.
Key clinical message: Recognizing atypical cases, such as the one presented, is of utmost importance. It is crucial for quick and adequate surgical and therapeutic intervention. This knowledge equips medical professionals with the necessary skills to handle similar situations in the future. The presented clinical case testifies the effectiveness of using A-PRF-membrane to prevent scar formation during wound healing.

Figures

References

    1. Hallab L, Taleb B. Facial Erysipelas: A Case Report. Integrative Journal of Medical Sciences. 2021;8. https://doi.org/10.15342/ijms.2021.315
    2. Ezemma O, Korman AM, Wang HE, Kaffenberger B. Diagnostic methods for the confirmation of non-purulent cellulitis: a review. Arch Dermatol Res. 2023 Nov;315(9):2519-2527. doi: 10.1007/s00403-023-02658-7. Epub 2023 Jul 8. PMID: 37421422.
    3. Brishkoska-Boshkovski V, Dimitrovska I, Kondova-Topuzovska I. Clinical Presentation and Laboratory Characteristics in Acute and Recurrent Erysipelas. Open Access Maced J Med Sci. 2019 Mar 14;7(5):771-774. doi: 10.3889/oamjms.2019.213. PMID: 30962836; PMCID: PMC6447339.
    4. Kozłowska D, Myśliwiec H, Kiluk P, Baran A, Milewska AJ, Flisiak I. Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelas. Przegl Epidemiol. 2016;70(4):575-584. English, Polish. PMID: 28221013.
    5. Andreychyn MA(Ed.). Infectious diseases in general practice and family medicine. TDMU "Ukrmedknyha" 2007 [in Ukrainian].
    6. Sadighi Akha AA, Csomós K, Ujházi B, Walter JE, Kumánovics A. Evolving Approach to Clinical Cytometry for Immunodeficiencies and Other Immune Disorders. Clin Lab Med. 2023 Sep;43(3):467-483. doi: 10.1016/j.cll.2023.05.002. Epub 2023 Jun 9. PMID: 37481324.
    7. Shapoval SD, Vasylevska LA, Bielinska VO. Clinical features and principles of differential diagnosis of erysipelas. The Ukrainian Journal of Clinical Surgery. 2021 Mar 28; 88(1-2):61-8. doi: 10.26779/2522-1396.2021.1-2.61
    8. Michael Y, Shaukat NM. Erysipelas. 2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30335280.
    9. Plagens-Rotman K, Przybylska R, Gerke K, Adamski Z, Czarnecka-Operacz M. 55-year old woman with erysipelas. Postepy Dermatol Alergol. 2020 Aug;37(4):613-616. doi: 10.5114/ada.2020.98225. Epub 2020 Sep 2. PMID: 32994788; PMCID: PMC7507150.
    10. Krasagakis K, Valachis A, Maniatakis P, Krüger-Krasagakis S, Samonis G, Tosca AD. Analysis of epidemiology, clinical features and management of erysipelas. Int J Dermatol. 2010 Sep;49(9):1012-7. doi: 10.1111/j.1365-4632.2010.04464.x. PMID: 20931671.
    11. Scarano A, Inchingolo F, Scogna G, Leo L, Crisante A, Greco Lucchina A, Lorusso F. Xanthelasma palpebrarum removed with Atmospheric Plasma technique: 11-year follow up. J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2 Suppl. 1):181-185. doi: 10.23812/21-2supp1-18. PMID: 34281315.
    12. Datta I, Casanas B, Vincent AL, Greene JN. The red face: Erysipelas versus, parvovirus B19, SLE, and rosacea. Asian Biomed. 2009 Dec 1; 3:681-8.
    13. Buckland GT 3rd, Carlson JA, Meyer DR. Persistent periorbital and facial lymphedema associated with Group A beta-hemolytic streptococcal infection (erysipelas). Ophthalmic Plast Reconstr Surg. 2007 Mar-Apr;23(2):161-3. doi: 10.1097/01.iop.0000256161.79015.38. PMID: 17413641.
    14. Nadeem A, Espinosa JA, Lucerna AA. Case Report: Erysipelas Diagnosed in the Emergency Department.
    15. Brindle R, Williams OM, Barton E, Featherstone P. Assessment of Antibiotic Treatment of Cellulitis and Erysipelas: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 Sep 1;155(9):1033-1040. doi: 10.1001/jamadermatol.2019.0884. PMID: 31188407; PMCID: PMC6563587.
    16. Klotz C, Courjon J, Michelangeli C, Demonchy E, Ruimy R, Roger PM. Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome. Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):703-709. doi: 10.1007/s10096-019-03490-6. Epub 2019 Jan 26. PMID: 30685804.
    17. Miron RJ, Pinto NR, Quirynen M, Ghanaati S. Standardization of relative centrifugal forces in studies related to platelet-rich fibrin. J Periodontol. 2019 Aug;90(8):817-820. doi: 10.1002/JPER.18-0553. Epub 2019 Mar 1. PMID: 30730050.
    18. Clark D, Rajendran Y, Paydar S, Ho S, Cox D, Ryder M, Dollard J, Kao RT. Advanced platelet-rich fibrin and freeze-dried bone allograft for ridge preservation: A randomized controlled clinical trial. J Periodontol. 2018 Apr;89(4):379-387. doi: 10.1002/JPER.17-0466. PMID: 29683498; PMCID: PMC6483085.
    19. Caruana A, Savina D, Macedo JP, Soares SC. From Platelet-Rich Plasma to Advanced Platelet-Rich Fibrin: Biological Achievements and Clinical Advances in Modern Surgery. Eur J Dent. 2019 May;13(2):280-286. doi: 10.1055/s-0039-1696585. Epub 2019 Sep 11. PMID: 31509878; PMCID: PMC6777161.
    20. Titou H, Ebongo C, Bouati E, Boui M. Risk factors associated with local complications of erysipelas: a retrospective study of 152 cases. Pan Afr Med J. 2017 Feb 5;26:66. doi: 10.11604/pamj.2017.26.66.11096. PMID: 28451043; PMCID: PMC5398858.

Social Icons

PUBLISH YOUR RESEARCH

We publish a wide range of article types in biology, medicine and engineering with no editorial biases.

Submit

See Manuscript Guidelines and APC

Explore the IgMin Subjects
Google Scholar
welcome Image

Google Scholar, beta-launched in November 2004, acts as an academic navigator through vast scholarly seas. It covers peer-reviewed journals, books, conference papers, theses, dissertations, preprints, abstracts, technical reports, court opinions, and patents. Search IgMin Articles